Product manager Emmanuel Naouri walks us through the new instrument and its features, including consumables that can be stored at room...

Chief International Officer Bobby Soni describes all the different ways that BI supports entrepreneurs such as grants, facilities,...

Entrepreneurship and Business Development Director Marco Delise describes the facilities available at SBC and the types of companies that...

Laura Niklason shows us what Humacyte's Human Acellular Vessel (HAV) looks like, describes how it is manufactured, explains its utility,...

Dean of Biomedical Studies Kristy Shuda McGuire describes how the BTT program trains community college and other students in lab work,...

Thomas Renn, Head of Europe for Breakthrough Properties, introduces us to this state-of-the-art facility that will encompass 214,000...

CEO Derek Jones describes how the campus is designed to augment the public research taking place at Babraham Institute with a community of s

Professor Matthew Wood explains the idea behind this biotech startup incubator and also shares his expertise on the latest in neuroscience.

CEO Murat Cirit describes how the liver tissue chip and accompanying software is meant to improve the quality of preclinical research.

Chaitan Khosla, Director of the Innovative Medicines Accelerator, describes how Stanford goes extra lengths to turn its research into...

BiotechTV visited the Freemont, CA headquarters of Ultima Genomics and spoke with CEO Gilad Almogy about their approach.

Cognito CEO Brent Vaughan introduces the company's device and walks us through the randomized P2 study.

ChemoMetec's VP of Operations Jonas la Cour walks us through his company's NucleoCounter technology.

LumaCyte SVP Colin Hebert walks us through the company's Radiance platform instrument.

Lonza Sales Manager Jerry Jiang walks us through the company's automated cell therapy manufacturing platform.

Thermo Fisher Scientific Senior Manager Russell Jerres walks us through the DynaCellect, Rotea, and Xenon systems.

Stephen Dilly describes how Codexis is trying help RNA companies use enzymes to more efficiently make oligonucleotides.

Co-Founders Serge Saxonov and Ben Hindson give us a corporate overview and demonstrate the Chromium single cell platform.

Co-founder, Chairman & CEO Ken Drazan explains the array of applications that Arsenal engineers into its CAR-T cells.

CEO Fabian Gerlinghaus shares a business overview and VP of R&D Daniele Malleo gives a hands on tour of how the Cell Shuttle works.